Literature DB >> 11150648

Dissociation of analgesic and rewarding effects of endomorphin-1 in rats.

A M Wilson1, R D Soignier, J E Zadina, A J Kastin, W L Nores, R D Olson, G A Olson.   

Abstract

The mu-receptor is the primary mediator of the effects of morphine and the endogenous opiates, endomorphin-1 and endomorphin-2. Here we demonstrate a dissociation of the analgesic and rewarding effects of endomorphin-1 in rats. Tail-flick results revealed that endomorphin-1 produced significant analgesic effects within 10-min after injection. However, it failed to show reward properties in the standard 45- min conditioned place preference (CPP) paradigm or in an abbreviated 10-min pairing which paralleled the time frame of the tail-flick findings. Morphine induced both analgesia and reward. Endomorphin-1 therefore is the first mu opiate shown to produce potent analgesia in the absence of reward behavior, and thus may have significant clinical potential.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11150648     DOI: 10.1016/s0196-9781(00)00340-5

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.

Authors:  Tingyou Li; Kimitaka Shiotani; Anna Miyazaki; Yuko Tsuda; Akihiro Ambo; Yusuke Sasaki; Yunden Jinsmaa; Ewa Marczak; Sharon D Bryant; Lawrence H Lazarus; Yoshio Okada
Journal:  J Med Chem       Date:  2007-05-12       Impact factor: 7.446

2.  Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Gino Lucente; Federica Feliciani; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

Review 3.  Efficacy and ligand bias at the μ-opioid receptor.

Authors:  E Kelly
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

4.  Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens.

Authors:  Abraham Zangen; Satoshi Ikemoto; James E Zadina; Roy A Wise
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

5.  Preemptive intrathecal administration of endomorphins relieves inflammatory pain in male mice via inhibition of p38 MAPK signaling and regulation of inflammatory cytokines.

Authors:  Ting Zhang; Nan Zhang; Run Zhang; Weidong Zhao; Yong Chen; Zilong Wang; Biao Xu; Mengna Zhang; Xuerui Shi; Qinqin Zhang; Yuanyuan Guo; Jian Xiao; Dan Chen; Quan Fang
Journal:  J Neuroinflammation       Date:  2018-11-15       Impact factor: 8.322

6.  Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2.

Authors:  Justyna Piekielna-Ciesielska; Adriano Mollica; Stefano Pieretti; Jakub Fichna; Agata Szymaszkiewicz; Marta Zielińska; Radzisław Kordek; Anna Janecka
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 7.  Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.

Authors:  Yeon Sun Lee
Journal:  Biomolecules       Date:  2022-09-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.